Value Research and Alphave data place Divi’s Laboratories shares at ₹11,150 on Nov. 17, a 0.63% gain after a 3.16% prior-session fall.
The ₹70 gain lifted the price from Nov. 16’s ₹11,080 close. StockAnalysis’ history lists 903,749 shares traded in that session, when the stock fell 3.16%.
A Nov. 7 company release reported consolidated total income of ₹3,770 crore and profit after tax of ₹1,127 crore for the quarter ended Sept. 30. Year-earlier figures were ₹2,860 crore and ₹689 crore, respectively.
During the Nov. 7 earnings call, Whole-Time Director – Commercial Nilima Prasad Divi said any bonus-share decision rested with the board. The filing’s subject was the quarterly and half-year results, and it disclosed no bonus-share authorization.



